NeoMD | ADHD medication unlikely to raise risk of self-harm, international study finds

ADHD medication unlikely to raise risk of self-harm, international study finds

New research indicates that self-harm risk in people with ADHD is highest before starting medication, suggesting ADHD treatments do not increase this risk.

NeoMD Editors · 2026-10-23 · 02:43 AM EDT

For information, not personal medical advice. Discuss treatment decisions with a qualified clinician.

The quick read

Key takeaways

An international study found that individuals with ADHD face a higher risk of self-harm before starting medication rather than after treatment begins.
The study combined data from multiple countries and focused on timing of self-harm events relative to ADHD medication initiation.
Findings suggest that ADHD medications are unlikely to increase self-harm risk, highlighting the importance of timely diagnosis and treatment of ADHD symptoms.

Editorial illustration for ADHD medication unlikely to raise risk of self-harm, international study finds

AI-generated editorial illustration.

A recent international study led by Aston University examined the risk of self-harm among individuals diagnosed with attention deficit hyperactivity disorder (ADHD).

What the research found

The study, published in the journal BMJ Mental Health, found that people with ADHD are at greater risk of self-harm before beginning ADHD medication, rather than after they start treatment. This suggests that the medication itself is unlikely to increase the risk of self-harm.

Understanding the evidence

This research combined data from multiple countries, making it one of the larger studies on this topic. It focused on the timing of self-harm events relative to the start of ADHD treatment.

Supporting editorial illustration for ADHD medication unlikely to raise risk of self-harm, international study finds — AI-generated editorial illustration.

Limitations and unknowns

While the study shows a correlation between self-harm risk and medication timing, it cannot prove cause and effect. Other factors associated with the decision to begin treatment might influence self-harm risk.

The study did not provide detailed information on the types of ADHD medication used, nor on individual patient differences that might affect outcomes.

Possible implications

These findings may reassure patients, families, and clinicians worried that ADHD medications increase self-harm risk. Instead, the data suggest that untreated ADHD symptoms might contribute most to this risk, emphasizing the importance of timely diagnosis and treatment.

Source: Medical Xpress